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 Abstract 
 
Introduction: Musculoskeletal conditions or injuries to the shoulder are frequently seen within 
primary healthcare practice, with a number of these complaints resulting in restricted joint 
mobility.  It is known that minor restrictions to movement, particularly those that disrupt the 
normal gait cycle, result in an increased energy demand.  Though previous studies have not 
demonstrated any increase in energy demand during a level walking task with an immobilised 
upper limb, the extent to which upper limb immobilisation during stair climbing has on 
physiological outcomes has yet to be determined. 
 
Purpose: The objective of this study was to measure the effect of unilateral restriction of upper 
limb on energetic cost of stair climbing.  
 
Methods: Thirty four participants, 16 males (age 28 ± 9 years, height 181 ± 6cm, weight 75 ± 
13kg) and 18 females (age 23 ± 4 years, height 170 ± 5cm, weight 64 ± 6kg) ascended a public 
access staircase at a rate of 80 steps.min
-1 
for five minutes and fifteen seconds over two 
experimental trials.  Participants were randomly assigned to conduct the trial with complete 
mobility, followed by immobilisation of the dominant (n=17) or non-dominant (n=17) upper 
extremity, or vice versa.  Outcome measures of oxygen uptake (mL.kg
-1
.min
-1
), total energy cost 
(kcal.d
-1
), relative energy expenditure (kcal.d
-1
.kg
-1
) and heart rate (beats.min
-1
) were recorded 
and utilised in data analysis, relating to pre- (0 minutes 0 seconds) versus post- (5 minutes 15 
seconds) the experimental time both within and between the groups (immobilised and non-
immobilised).  
 
Results: Post stair climb data shows only a trivial to small difference in the physiological 
measures of the non-immobilised and immobilised groups (oxygen uptake; 1.4 ± 0.5 and 1.4 ± 
0.4mL.min
-1
.kg
-1
, heart rate; 58 ± 16 and 59 ± 16beats.min
-1
, total energy cost; 9858 ± 3560 and 
10499 ± 3062kcal.d
-1
, and relative energy expenditure 139 ± 42 and 149 ± 39kcal.d
-1
.kg
-1
, 
respectively).  A trivial to small difference in the physiological measures in the two groups prior 
to the stair climb task (oxygen uptake; 0.5 ± 0.2 and 0.5 ± 0.2mL.min
-1
.kg
-1
, heart rate; 103 ± 19 
and 106 ± 14beats.min
-1
, total energy cost; 3711 ± 1555 and 3362 ± 1419kcal.d
-1
, and relative 
energy expenditure 53 ± 23 and 48 ± 21kcal.d
-1
.kg
-1, 
, respectively) and a large difference pre- to 
post- the stair climbing task in the outcome measures was observed.  Additional analysis 
 demonstrates only a trivial to small difference in the physiological measures between order of 
immobilisation, and between immobilisation of the dominant or non-dominant upper limb.   
 
Conclusion: Immobilisation of the upper limb had only a trivial to small effect on oxygen uptake, 
heart rate, total energy cost, and relative energy expenditure during a stair climbing task. 
 
Keywords: arm swing; metabolic cost; locomotion; heart rate; energy expenditure; oxygen 
uptake; oxygen kinetics. 
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 Chapter one 
 
Literature Review 
 
Introduction 
 
In 2004, the Accident Compensation Corporation New Zealand documented that shoulder 
injuries were the third most common musculoskeletal complaint in general practice 
clinics, which included medical practitioners, physiotherapists and osteopaths (Accident 
Compensation Corporation, 2004).  These injuries often result in restriction of normal 
shoulder range of movement or immobilisation of the upper limb by a sling.  Minor 
restrictions to movement, such as those imposed by a sling, may disrupt normal gait and 
alter the efficiency of the musculoskeletal system, therefore imparting a greater metabolic 
cost (Greenman, 1996, p. 11).  Based on the hypothesis stated by Greenman (1996) the 
objective of this study was to model a musculoskeletal system dysfunction by imposing a 
unilateral restriction of upper limb movement to observe the physiological responses to a 
stair climbing task. 
 
The aim of this review is to provide a brief overview of the literature pertaining to upper 
limb joint restriction during stair climbing.  In particular, the biomechanics of joint 
restriction and consequent physiological effects were of interest.  Literature for this 
review was sourced primarily from databases (Medline, SPORTDiscus, PubMed and 
ScienceDirect), Google Scholar, and textbooks using the following keywords; 
immobilisation, locomotion, stair climbing, upper limb, arm swing, gait and energy 
expenditure. 
 
This search lead to the identification of the key themes for discussion.  The review of 
literature is set out in three parts.  Section one introduces the biomechanics of stair 
climbing in relation to lower and upper limb movement.  Section two discusses the 
physiological responses to an exercise task.  Section three outlines the importance of 
physical activity and exercise and how stair climbing is a beneficial form of exercise.  
 Finally section four discusses the physiological and biomechanical changes in the lower 
and upper limb following immobilisation during both level walking and stair climbing, 
leading into a conclusion and the study objective. 
  
 1. Biomechanics of Stair Climbing and Locomotion in the Lower and Upper 
Limb 
 
1.1 Lower limb 
1.1.1 Stair climbing versus level walking 
Stair climbing is a modified form of level walking (Trew & Everett, 2005, p. 185).  
Compared to level walking, stair climbing requires an increased joint range of motion, 
particularly at the hip and knee, and involves increased muscular activity to generate 
forces that vertically translate the body‟s centre of gravity (Andriacchi, Andersson, 
Fermier, Stern, & Galante, 1980; Trew & Everett, 2005, p. 185).  Stair climbing is 
potentially a more biomechanically and physiologically challenging task than level 
walking as the individual has to work against gravity to ascend to the next step 
(Protopapadaki, Drechsler, Cramp, Coutts, & Scott, 2007). 
 
1.1.2 Phases of stair climbing 
1.1.2.1 Stance phase 
The stance phase is where one foot is in contact with the ground while the other foot is in 
the swing phase.  Stance phase is partitioned into weight acceptance, pull up and forward 
continuation of movement (McFayden & Winter, 1988).  On contact with the step, weight 
is typically placed on the anteriomedial third of the foot and then transferred throughout 
the whole foot (McFayden & Winter, 1988; Trew & Everett, 2005, p. 186).  Once the 
body weight is transferred through the foot, the ankle is dorsiflexed while the hip and 
knee joints are flexed (Andriacchi, et al., 1980; Reiner, Rabuffetti, & Frigo, 2002).  
Concentric contraction of the hip extensors (gluteus maximus and the posterior fibres of 
gluteus medius and minimus muscles), knee extensors (rectus femoris, vastus medialis, 
vastus intermedialis and vastus lateralis), and the ankle plantarflexors (soleus, 
gastrocnemius, tibialis posterior and plantaris) pull the body‟s centre of gravity 
superiorly, lifting the rear foot off the ground into the single stance phase (McFayden & 
Winter, 1988).  The single stance phase is where only one foot is in contact with the 
stepping surface.  Consequently, there is a greater potential risk of falling during this 
phase, making sound balance essential (Trew & Everett, 2005, p. 186).  During this 
 single stance phase, the hip abductor muscle group, primarily gluteus medius, is active to 
stabilise and prevent the pelvis from dropping to the unsupported side (McFayden & 
Winter, 1988).  Forward continuation of movement is maintained by the hip and knee 
extensor muscles.  Activation of the quadriceps muscle group maintains knee joint 
position, while the ankle plantarflexes to propel the limb into the swing phase. 
 
1.1.2.2 Swing phase 
Swing phase refers to the foot that is not in contact with the ground and is moving to the 
next step.  This phase is partitioned into simultaneous foot clearance and lifting of the 
swinging limb and foot placement (McFayden & Winter, 1988).  Foot clearance and 
lifting of the swinging limb act to move the limb past the immediate step and onto the 
next step.  This movement is achieved initially by concentric contraction of the tibialis 
anterior muscle to dorsiflex the ankle, followed by the hamstrings muscle group to flex 
the knee joint and the iliopsoas muscle to flex the hip joint to pull the leg onto the next 
stair.  Concurrently, eccentric contraction of the quadriceps muscle group occurs to 
control any unwanted knee flexion.  A greater degree of concentric than eccentric 
muscular activity (in stair ascension) results in excessive hip and knee flexion causing the 
swinging limb to move much higher than the step before foot placement.  Foot placement 
is controlled by eccentric activity of the hip flexors, primarily the iliopsoas muscle, to 
allow the hip to extend, lowering the limb to make contact with the next step (Andriacchi, 
et al., 1980; McFayden & Winter, 1988).  Throughout the swing phase, tibialis anterior 
contracts to maintain ankle dorsiflexion required for step clearance, and works 
eccentrically before foot placement to control ankle plantarflexion to meet the step in 
preparation for weight bearing (Andriacchi, et al., 1980; McFayden & Winter, 1988). 
 
1.2 Upper limb 
1.2.1 Role of the upper limb during locomotion 
Upper limb movement occurs primarily within the four joints of the shoulder 
(glenohumeral, acromioclavicular, sternoclavicular and scapulothoracic) and to a lesser 
degree of movement occurring at the elbow joint (Trew & Everett, 2005, p. 175).  The 
importance of the upper limb during locomotion is that it acts as a rhythmic pendulum, 
 moving in an anti-phase to the striding lower limb (Grimshaw, Lees, Fowler, & Burden, 
2007, p. 252) and provides a counterbalance to lower limb movement (Hanada & 
Kerrigan, 2001; Kapandji, 1987, p. 184). 
 
Upper limb movement during locomotion is divided into forward (flexion) and backward 
(extension) swinging motions.  Fernandez Ballesteros, Buchthal & Rosenfalck (1965) 
state that the forward swinging action is driven passively by momentum, as they 
demonstrated little electromyographic activity in the primary flexor muscles of the 
shoulder (the anterior deltoid and the clavicular part of pectoralis major).  Initiation and 
movement into extension is controlled by the primary shoulder extensor muscles (middle 
and posterior deltoid, lattisimus dorsi, and teres major), with both supraspinatus and 
trapezius muscles active throughout the forward and backward swing (Fernandez 
Ballesteros, et al., 1965; Norkin & Levangie, 1992, p. 86).  To ensure adequate trunk 
clearance of the swinging arm,  muscular activity occurs in the shoulder abductor muscles 
of the middle deltoid, pectoralis major, subscapularis, teres major, and lattisimus dorsi 
(Fernandez Ballesteros, et al., 1965; Kapandji, 1987, p. 185). 
 
Fernandez Ballesteros et al. (1965) and Li, Wang, Crompton & Gunther (2001) 
demonstrated that muscular activity within the upper limb continues even when 
movement of the arm is restricted.  Continuation of muscular activity in a restricted upper 
limb was conceptualised by Gray (1944) as a neurally driven activity that has been 
retained from when our forearms were used to locomote.  Upper limb movement during 
locomotion is an integral part of the dynamics of movement, essential in generating 
smooth, non-jerky movement (Jackson, 1983; Jackson, Joseph, & Wyard, 1978; Li, et al., 
2001).  Jackson, Joseph & Wyard (1983a) and Jackson, Joseph & Wyard (1983b) 
concluded that activation of a central motor pattern and muscular control of the upper 
limb occur concurrently and seem to be the most likely reasons for retention of upper 
limb movement. 
  
 2. Physiological Responses to Exercise 
 
The cardiorespiratory responses of cardiac output, blood pressure, and oxygen 
consumption increase in response to performing physical exercise in order to supply 
adequate oxygen and nutrients to exercising skeletal muscle (Laughlin, 1999; Widmaier, 
Raff, & Strang, 2004, p. 141).  These responses are controlled, in part, by chemical 
changes systemically (peripheral skeletal musculature and vasculature) that activate 
baroreceptors and muscle chemoreceptors (McCloskey & Mitchell, 1972).  In addition, 
central command centres control the cardiovascular responses in anticipation of exercise 
and during activity (Green, et al., 2007; Widmaier, et al., 2004, p. 145).  Performing 
physical exercise also imparts a metabolic cost on the individual that varies between 
differing exercise modalities and intensities. 
 
2.1 Influence of exercise on cardiac output 
In order to meet oxygen demand in exercising skeletal muscle, cardiac output increases to 
provide a greater amount of oxygenated blood.  This increase is mostly due to a rise in 
heart rate as stroke volume reaches a plateau and possibly diminishes towards the upper 
end of exercise intensity. The increase in heart rate is mediated by several factors such as 
regulation by the autonomic nervous system (Wilmore, Costill, & Kenney, 2008, p. 79), 
influence of catecholamines and other factors such as age, gender and temperature.  
 
During exercise, the autonomic nervous system changes the balance between the 
sympathetic and parasympathetic systems resulting in an increased sympathetic and 
decreased parasympathetic activity (Bray, Cragg, Macknight, Mills, & Taylor, 1986, p. 
101).  Increased sympathetic activation occurs partly as a result of chemical changes 
(such as increases in hydrogen concentration, blood lactate concentration, carbon dioxide 
content and reduction in oxygen availability) within the systemically that are detected by 
muscle chemoreceptors.  Afferent signals are then transmitted to the medullary 
cardiovascular centre, comprised of an inhibitory and acceleratory centre.  If the 
cardioacceleratory centre is stimulated impulses are sent along the thoracic spinal cord 
and sympathetic accelerator nerves to the sinoatrial node, atrioventricular node, heart 
 muscle, and coronary arteries (Marieb, 2004, p. 625).  These nerves release the 
catecholamine noradrenaline onto the β-adrenergic receptors of the heart.  Stimulation of 
these receptors by noradrenaline promotes the sympathetic response of an increased in 
the force of cardiac myocyte contraction and an increased heart rate that leads to an 
increase in cardiac output (Bray, et al., 1986, p. 104; Klabunde, 2005, p. 56; Widmaier, et 
al., 2004, p. 151).  If the cardioinhibitory centre is activated a parasympathetic response 
predominates subsequently decreasing heart rate.  Stimulation of this centre sends 
impulses to the dorsal motor nucleus of the vagus nerve within the medulla, which in turn 
sends inhibitory signals to the heart via branches of the vagus nerve terminating in the 
heart muscle wall, sinoatrial and atrioventricular nodes.   
 
Catecholamines, such as adrenaline and noradrenaline have a chemical influence on 
cardiac output during exercise.  In response to stimulation of the sympathetic nervous 
system, adrenaline is liberated from the adrenal medulla and noradrenaline is released 
from the sympathetic nerves.  These catecholamines cause an increase in heart rate and 
consequently cardiac output to prepare the individual for physical activity or to facilitate 
current physical activity (Guyton & Hall, 2000, p. 110). 
 
It is well established that maximum heart rate declines with age (Marieb, 2004, p. 628), 
and that females have a slightly faster average resting heart rate than men (Gillum, 1988).  
Alterations in resting heart rate with age are not as clear (Fogari, et al., 1997). An 
increase in body temperature, for example during exercise or fever, causes an increase in 
heart rate and a temporary increase in the contractile strength of the heart (Guyton & 
Hall, 2000, p. 112).  These effects are thought to occur as an increase in temperature 
causes an increased permeability of the cardiac muscle to controlling ions (potassium and 
calcium) that increase the hearts self-excitation process (Guyton & Hall, 2000, p. 112).     
 
2.2 Influence of exercise on blood pressure and redistribution of blood flow 
Blood pressure response to upright aerobic exercise is a progressive increase in systolic 
pressure with a maintenance or slight decrease in diastolic pressure (Kelley & Kelley, 
2000).  The increase in systolic pressure is due to the increase in cardiac output that 
 increases as a consequence of an increase in heart rate.  The slight decrease in diastolic 
blood pressure, however, is primarily due to peripheral vasodilatation that occurs during 
exercise as blood moves away from the capillaries to the skeletal muscle (Bray, et al., 
1986, p. 89).  This normal response may change in older patients, those with an 
underlying cardiovascular condition, or patients on certain medications (Protogerou, et 
al., 2007).   
 
The normal response to an increase in energy demand by skeletal muscles during exercise 
is a vasoconstriction in the arterioles and capillaries leading to and surrounding tissues 
that require minimal blood supply to function (such as the kidney and digestive organs).  
In contrast, vasodilation occurs in the vasculature leading to and surrounding tissues 
demanding greater blood flow.  This vasodilation occurs in exercising skeletal muscle to 
provide the oxygen required for energy production, in the coronary circulation to increase 
the amount of oxygenated blood to the heart muscle, and in the skin to allow heat 
dissipation.  Cerebral blood flow remains relatively unchanged. 
 
2.3 Influence of exercise on oxygen consumption 
Various metabolic pathways produce the energy required to complete an exercise task.  
At rest, or light to moderate intensity exercise lasting approximately ten minutes to 
several hours, 90 to 95% of the energy demands are met by the process of aerobic 
glycolysis, a sequence of cellular, chemical reactions to hydrolyse glucose in the presence 
of oxygen (Bray, et al., 1986, p. 90; Klabunde, 2005, p. 99; Marieb, 2004, p. 774).   This 
process culminates in a relatively high adenosine triphosphate (ATP) yield.  In order to 
generate sufficient ATP aerobically, oxygen needs to be delivered to and utilised by the 
skeletal muscle mitochondria (Tschakovsky & Hughson, 1999).  The remaining (5 to 
10%) energy yield is met by the phosphorylation of stored substrates (such as 
phosphocreatine or glucose when oxygen is in insufficient supply) or the hydrolysis of 
ATP. 
 
Utilisation of oxygen during exercise can be represented in three stages.  The initial, 
cardiodynamic phase (I) represents the oxygen exchange occurring within the first few 
 breaths during exercise and is associated with increased pulmonary blood flow due to an 
increase in cardiac output (Jones & Poole, 2005, p. 14).  The second, fast phase (II) 
represents deoxygenated blood leaving exercising musculature and travelling via the 
heart to the lung.  The rate at which oxygen uptake increases over time during the non-
steady state phases (I and II) depicts the ability of the circulatory system to deliver 
oxygen, the cells to utilise oxygen, and the venous system to return blood to the lungs 
ready for reoxygenation (Jones & Poole, 2005, p. 15). 
 
The third, steady state phase (III) corresponds to the point at which carbon dioxide 
plateaus and venous oxygen content reaches its lowest point during moderate intensity 
exercise (Jones, Koppo, & Burnley, 2003, p. 15).  Steady state oxygen uptake (phase III) 
is normally reached within two to three minutes in moderate intensity exercise (Jones, et 
al., 2003; Jones & Poole, 2005, p. 16; Whipp & Wasserman, 1972).  At higher exercise 
intensities, attainment of a steady state may be delayed for up to 15 minutes (Henry & 
DeMoor, 1956; Jones & Poole, 2005, p. 15; Whipp & Wasserman, 1972) or completely 
absent (Poole, Ward, Gardner, & Whipp, 1988; Roston, et al., 1987; Whipp, 1987).  
Indeed, there is considerable debate as to whether a „true‟ maximum oxygen uptake is 
ever reached (Hill, Long, & Lupton, 1924; Noakes, 2000). 
 
2.4 Influence of exercise on metabolic energy expenditure 
 
Energy is expended in order to maintain essential body functions such as breathing and 
heart rate, for tissue growth and repair, and to allow the ability to perform physical 
activity.  To reduce the metabolic cost on the individual, there is an evolutionary 
tendency to minimise the degree of energy expended during everyday tasks (Sparrow, 
2000, p. 13).  Therefore, frequently conducted tasks, such as walking or talking, are 
associated with minimal metabolic costs.  On the other hand, skilled movements or high 
intensity/duration muscular activities, require a greater degree of muscular activation.  
Further, the metabolic cost associated with a task could be minimised if the individual 
becomes more practised or „skilled‟ at the task (Sparrow & Newell, 1998).  Sparrow 
(2000, p. 14) showed that the level of muscular activation during movement is positively 
correlated with metabolic energy expenditure.   
 Greenman (1996, p. 11) discussed how the musculoskeletal system is a major expender 
of total body energy.  Increased activity of the musculoskeletal system during physical 
activity places a greater demand upon the internal viscera to develop and deliver the 
energy required to perform the exercise.  Greater demand results in a greater degree of 
energetic cost.  If the efficiency of the musculoskeletal system is compromised by 
dysfunction, particularly if normal gait is not preserved, a greater energetic cost occurs.  
This greater cost is incurred not only during physical activity, but for daily physical 
activity as well.    
 
  
 3. Importance of Physical Activity and Exercise in the Maintenance of Health 
 
The 2006/7 New Zealand Health Survey showed only half of all New Zealand adults 
were regularly physically active, completing at least 30 minutes of physical activity per 
day on five or more days of the last week.  Further, 15% of adults reported being 
involved in less than 30 minutes of exercise in the last week (Ministry of Health, 2008).  
 
Encouraging and incorporating physical exercise into day to day activity would have 
considerable health benefits for both the individual and the population as a whole 
(Ministry of Health, 2008).  An increased level of physical activity has shown to be 
protective against heart disease (Berlin & Colditz, 1990; Ignarro, Balestrieri, & Napoli, 
2007), type II non-insulin dependent diabetes (Burr, Rowan, Jamnik, & Riddell, 2010) 
and certain forms of cancer (colon (Colditz, Cannuscio, & Frazier, 1997), post-
menopausal breast (Schmidt, et al., 2008), lung and endometrial (Friedenreich, 2001)).  
Exercise also helps to lower blood pressure, which is a risk factor for heart disease and 
type II diabetes (Whelton, Chin, Xin, & He, 2002).  Further, in populations greater than 
45 years of age, a quarter of type II diabetes cases and half the number of hip fractures 
could be avoided with appropriate exercise (Whitehead, 1995). 
 
Based on the numerous health benefits of regular physical activity and the findings of the 
2006/7 New Zealand Health Survey, Sport and Recreation New Zealand‟s PushPlay 
scheme was developed to inspire the nation to become more active.  PushPlay 
recommends at least 30 minutes a day of moderate intensity physical activity on most 
days of the week, which can be cumulative over the course of the day. Sport and 
Recreation New Zealand (2008) PushPlay website lists the first quick tip for becoming 
active as „taking the stairs instead of the lift‟, indicating stairs as an easy, ever-present 
form of exercise with numerous health benefits. 
 
3.1 Stair climbing as exercise 
Stair climbing is a beneficial form of exercise that has been shown to improve 
cardiovascular fitness (Boreham, Wallace, & Nevill, 2000; Fardy & Ilmarinen, 1975; 
 Ilmarinen, et al., 1979; Loy, et al., 1994), reduce cholesterol levels (Boreham, et al., 
2000), reduce percentage body fat (Fardy & Ilmarinen, 1975), and has a positive 
association with bone mineral density (Coupland, et al., 1999).  Based on the study 
findings by (Bassett, et al., 1997) and Teh & Aziz (2002), stair climbing requires almost 
10 times greater energy expenditure than at rest and is therefore considered as moderate 
to vigorous exercise.  In addition, stair climbing has been suggested as a beneficial form 
of exercise due to its presence at most places of residence or employment, that it does not 
incur any monetary cost (Teh & Aziz, 2002), and that it is a more physiologically and 
biomechanically challenging task than normal walking (Eves, Webb, & Mutrie, 2006; 
Protopapadaki, et al., 2007). 
 
  
 4. Physiological and Biomechanical changes during Stair Climbing and 
Immobilisation 
 
4.1 Physiological and biomechanical changes within the lower limb during stair 
climbing 
Greenman (1996, p. 11) states that movement restriction in one of the major joints in the 
lower limb can increase the energetic cost of normal walking by up to 40% and up to 
300% if two joints are restricted.  As stair climbing requires greater muscular activity 
than level walking (Andriacchi, et al., 1980), it is assumed that the energetic cost of stair 
climbing with a lower limb dysfunction would be considerable.  Numerous studies, such 
as those by Andriacchi, Galante & Fermier (1982); Bergmann, Graichen and Rohlmann 
(1995); Powers, Boyd, Torburn, & Perry (1997); Thambyah, Thiagarajan, & Goh Cho 
Hong (2004) and Asay, Mündermann & Andriacchi (2008) to name a few, have been 
conducted to demonstrate how biomechanical changes in the lower limb influence the 
individual‟s ability to climb stairs.  The works of all the aforementioned authors 
investigated the influence of hip or knee dysfunction, either due to an injury, surgery or 
degenerative process, on the individual‟s ability to ascend stairs.  These studies showed 
that dysfunction within a given lower limb resulted in a greater degree of muscular work 
and power output by either the contralateral or ipsilateral lower limb.  The dysfunctional 
change also results in slower stair climbing rates (Powers, et al., 1997), active adaptation 
of joint positioning (Thambyah, et al., 2004), and compensatory changes in the 
contralateral and ipsilateral hip, knee, and/or ankle joint angles (Asay, et al., 2008; 
Powers, et al., 1997). 
 
4.2 Physiological changes occurring following immobilisation of the upper limb 
Only a few studies have observed the effect of restricting upper limb movement on the 
energetics of level locomotion.  No known studies have investigated this effect during 
stair climbing.  The earliest technical report by Chapman & Ralston (1964) investigated 
the energetic cost of level walking when an upper and/or lower limb were restricted.  
Chapman and Ralston (1964) showed no „statistically significant change‟ in energy 
expenditure when upper limb movement was restricted.  The results of this initial study 
have been replicated by Park, Shin & Kim (2000) and Hanada & Kerrigan (2001) who 
 demonstrated that during level walking at slower walking speeds (of 1.1 and 1.2m.s
-1
) 
when normal movement of an upper limb was immobilised, there was a trivial difference 
in energy expenditure.  However, further studies by Park et al. (2000) and Umberger 
(2008) at greater walking speeds of 1.3 to 1.7ms
-1
, demonstrated a respective increase in 
energy expenditure from 2.9 ± 0.2 to 3.1 ± 0.2W.kg
-1
 (at p=0.004) and from 12.1 ± 2.5 to 
12.8 ± 2.7L.kg
-1
.min
-1 
when an upper limb was immobilised.  
 
4.2.1 Significance of upper limb immobilisation to the osteopathic profession 
In 2004, the Accident Compensation Corporation New Zealand found that shoulder 
injuries were the third most common musculoskeletal complaint in general practice, 
physiotherapy and osteopathic clinics (Accident Compensation Corporation, 2004).  A 
number of shoulder injuries can lead to restricted movement of the upper limb, including 
a recent shoulder dislocation, surgery, an acromioclavicular joint injury, or a 
musculoskeletal condition such as adhesive capsulitis or supraspinatus tendonitis.  As 
patients with these injuries are frequently discharged from care with an arm immobilised 
by a sling and due to the reasonably common occurrence of shoulder complaints, 
osteopaths in practice are often met by patients who have restricted movement of an 
upper limb.  Though healthy individuals can perform physical tasks such as climbing 
stairs rather easily, the task becomes more demanding when normal limb movement is 
restricted (Reiner, et al., 2002).  This increased demand may hinder the participant‟s 
ability to perform daily physical tasks and to exercise (Greenman, 1996, p. 11) and 
compromise the patients ability to maintain health. 
 
  
 5. Conclusion 
Greenman (1996, p. 11) states if a musculoskeletal dysfunction alters the efficiency of 
normal gait this has a detrimental effect on total body function in regards to metabolic 
demand.   This has indeed shown to be true for  the larger joints of the hip (E. Mattsson, 
1989; Waters, Barnes, Husserl, Silver, & Liss, 1988), knee (Abdulhadi, Kerrigan, & 
LaRaia, 1996; Hanada & Kerrigan, 2001; Eva Mattsson & Brostrom, 1990) and ankle 
(Eva Mattsson & Brostrom, 1990).  As movement of the upper extremity has been shown 
to be an essential component of efficient, non-jerky locomotion (Jackson, 1983; Jackson, 
et al., 1983a; Li, et al., 2001), the hypothesis of Greenman (1996, p. 11) should hold true 
for restrictions to upper extremity movement.  Though, previous studies into the energetic 
cost of level walking with an immobilised upper extremity have failed to find any 
increase in energetic cost when an individual‟s upper extremity is immobilised (Chapman 
& Ralston, 1964; Hanada & Kerrigan, 2001; Park, et al., 2000).  What has yet to be 
identified is if the energetic cost is influenced by immobilisation of an upper limb whilst 
conducting an every-day task of stair climbing.  From this, the objective of the study was 
to observe if immobilisation of an upper limb influenced the physiological responses to 
stair climbing when compared to normal upper limb movement. 
 
  
 Chapter two 
 
Manuscript 
 
1. Introduction 
 
A report by the Accident Compensation Corporation of New Zealand (2004) revealed 
that musculoskeletal complaints regarding the shoulder were the third most common 
compliant presenting to a general practice, physiotherapy or osteopathic clinic.  These 
injuries often result in restriction of normal shoulder range of movement or 
immobilisation of the upper limb by a sling.  Greenman (1996, p. 11) states that any 
minor restrictions to movement may disrupt the normal gait cycle and alter the efficiency 
of the musculoskeletal system, therefore imparting a greater metabolic demand. 
 
It has been demonstrated that upper limb movement is an integral part of the dynamics of 
normal locomotion (Eke-Okoro, Gregoric, & Larsson, 1997; Fernandez Ballesteros, et al., 
1965; Jackson, et al., 1983a, 1983b; Li, et al., 2001).  Chapman & Ralston (1964), Park, 
Shin & Kim (2000), and Hanada & Kerrigan (2001) understood the essential role that the 
upper limb plays during movement and conducted research to demonstrate if restricting 
upper limb movement during level walking imparted a greater energetic cost on the 
individual.  Chapman & Ralston (1964), Park et al. (2000), and Hanada & Kerrigan 
(2001) found that restriction of the upper limb during level walking had no effect on total 
energy cost when compared to unrestricted walking.  However, the extent to which upper 
limb immobilisation during stair climbing has on metabolic cost has yet to be determined. 
 
Based on the hypothesis of Greenman (1996, p. 11) and the lack of evidence regarding 
the physiological responses of immobilisation during a stair climbing task, the objective 
of this study was to model a musculoskeletal system dysfunction by imposing a unilateral 
restriction of upper limb movement. 
 
   
 2. Methods 
Participants 
Thirty four participants, 16 males (age 28 ± 9 years, height 181 ± 6cm, weight 75 ± 13kg) 
and 18 females (age 23 ± 4 years, height 170 ± 5cm, weight 64 ± 6kg) responded to 
recruitment posters placed on public notice boards around the Unitec campus (Auckland, 
New Zealand).  The sample size was determined using computer software ("G*Power," 
2008) in which the following assumptions were made: alpha level of 0.05, 80% power at 
a Type II error, and a moderate (0.5) effect size.  To be included in the study the 
participants had to be between 18 and 50 years of age, be walking more than one flight of 
stairs at least once a week as part of their everyday activity, be pain-free during walking 
and have no current, or recent history of shoulder complaint or injury.  Participants were 
excluded from the study if they had a history of a cardiovascular or respiratory disorder, 
thrombosis, asthma that required hospitalisation within the last five years, or a gait, 
rheumatological or upper motor condition.  Meeting these criteria was initially discussed 
on the first contact with the researcher and further confirmed using a health screening 
questionnaire at the beginning of the experimental trial.   
 
Apparatus 
The physiological outcome measures of oxygen uptake (L.kg
-1
.min
-1
), total energy cost 
(kcal.d
-1
), and relative energy expenditure (kcal.d
-1
.kg
-1
) were captured using the Cortex 
Metamax 3B cardiopulmonary exercise system (CORTEX Biophysik, Leipzig, Germany) 
(Figure 1).  Heart rate (beats.min
-1
) was captured using a Polar heart rate monitor (Polar 
T31 Transmitter, Polar NZ, Auckland, New Zealand).  The data were transferred to and 
stored within the Metasoft software programme (Figure 2).  The Metamax 3B system 
consisted of a breathing mask with an attached turbine and gas sampling line to determine 
the breathing frequency, breath-by-breath oxygen consumption and carbon dioxide 
production.  The Metamax 3B oxygen and carbon dioxide analysers are accurate to 0.1% 
volume, based on the manufactures‟ specifications.  The oxygen and carbon dioxide 
analysers were calibrated prior to every trial session based on the manufactures‟ 
recommendation.   
 
 The participant‟s age, gender, height, weight, level of physical activity (in hours/week) 
and the size of the breathing mask used were entered into the Metasoft programme.  
These parameters enabled the software to calculate the dead space volume of the 
breathing mask, which were then used in the calculation of total energy cost and relative 
energy expenditure.  An arm sling (Model number OPP3089, size Medium, Auckbritt, 
Auckland) was used to restrict movement of the participant‟s upper limb during their 
immobilised stair climbing trial (Figure 3).  A portable media player was worn by each 
participant that played an audio track of a metronome at a rate of 80 beats.min
-1
 running 
for 5 minutes and 15 seconds. 
 
[Insert Figure 1 here] 
 
[Insert Figure 2 here] 
 
[Insert Figure 3 here] 
 
Experimental Design 
The experiment was conducted in a 30-storey building in Auckland City, with 
appropriate permission from the Facilities Manager of Kiwi Income Property Trust.  
Ethical approval was obtained from the Unitec Research Ethics Committee (UREC).  All 
participants provided written formal consent to participate. 
 
Each participant ascended the stairs at a rate of 80 steps.min
-1
.  This stepping rate is based 
on similar previous studies by Boreham et al. (2000) and Teh & Aziz (2002) who found  
participant-selected brisk, yet comfortable walking paces during stair ascension of 80 and 
95 steps.min
-1
,
 
respectively.   
 
It is well known that steady state oxygen consumption is reached in approximately three 
minutes during a moderate intensity exercise task (Jones & Poole, 2005; Whipp & 
Wasserman, 1972).  Therefore, the experimental trial was conducted over a slightly 
 longer time period of 5 minutes and 15 seconds to ensure steady state oxygen 
consumption was reached for each participant.  
 
Before conducting the experiment, participants were given verbal and written instruction 
regarding the events of the experiment and were asked to complete a health screening 
questionnaire.  Each participant ascended the stairs twice, once with complete mobility 
and once with normal upper limb movement restricted by a sling.  The order of testing 
(immobilised group or non-immobilised group) and immobilisation of the dominant or 
non-dominant arm was randomly assigned among participants to prevent selection bias.  
This was done by allocation into either group by order of arrival to the experimental base.  
The heart rate monitor, breathing mask and portable media player were then placed on 
the participant.  The participant stood at rest for approximately two minutes whilst the 
Metamax 3B system analysed the ambient temperature, atmospheric oxygen and carbon 
dioxide concentrations.  Once completed, the participant was guided to the staircase.  
Before climbing, the participants were instructed to keep to the time of the metronome 
and that they could not stop or use the handrails.  The metronome track was played and 
the participant began climbing the staircase accompanied by the researcher. On 
conclusion of the metronome track, the participant pressed the play/pause button on the 
Metamax 3B system to indicate they had reached the end of their experimental trial.  The 
participant then climbed back down the stairs to the experimental base.  Over the course 
of the 5 minutes and 15 seconds, data were sent from the Metamax 3B system to the 
Metasoft programme via telemetry and was saved at the conclusion of each participants 
trial. 
 
The trial was repeated with either the participants dominant (n=17) or non-dominant 
(n=17) upper limb immobilised.  To immobilise the arm, the participant‟s arm was placed 
in a triangular sling, holding the shoulder in neutral flexion/extension, adduction and 
internal rotation, and the elbow at 90° of flexion.  Between each trial, the participant was 
given between 15 and 45 minutes to rest so that monitored measures could return to 
resting levels. 
 
 Data Management 
Over the course of each trial the Metamax 3B system randomly sampled the four 
outcome measures of oxygen uptake (L.kg
-1
.min
-1
), total energy cost (kcal.d
-1
), relative 
energy expenditure (kcal.d
-1
.kg
-1
) and heart rate (beats.min
-1
), within each participant and 
between participants, in a non-uniform time course.  This scenario was somewhat 
problematic and could not be adjusted.  As a consequence, data analysis related only to 
average pre- (0 minutes 0 seconds) versus average post- (5 minutes 15 seconds) the 
experimental time, and the difference between the two values.   
 
Individual data for each variable and for each group (immobilised and non-immobilised) 
can be found in Appendix 1.  From the individual data, the times to reach half end-point 
values across the outcome variables in both the immobilised and non-immobilised groups 
were calculated.   
 
Data values are expressed as means ± standard deviation.  Differences between groups 
and over time were expressed as multiples of a standard deviation (Effect Size).  
Precision of the estimates were expressed using 95% confidence limits and the clinical 
likelihoods of differences were expressed using a percent probability (Hopkins, 2009).  
Magnitudes of effect were interpreted according to the criteria of Cohen (1988, p. 71) and 
Hopkins (2009) in which effect sizes less than 0.2, from 0.2 to 0.49, from 0.5 to 0.69, and 
greater than 0.7 were regarded as trivial, small, moderate, and large respectively. 
 
Statistical Analysis 
Microsoft Excel software was used for collation of data and statistical analysis.  Paired t-
tests were computed for each variable between groups prior to the stair climb, within 
each group pre- to post-stair climb, and between groups for the overall change score (pre- 
to post-stair climb).  Further, paired and unpaired t-tests were computed to determine if 
order of immobilisation or immobilised upper limb (dominance) had an influence on the 
results.  The author did not adjust the confidence limits so as to hold the overall Type O 
error rate to 5%, the chance that any true value in this study falls outside its confidence 
interval (Hopkins, 2009). The author is of the opinion that, in publishing precision of 
 estimates, controlling error rate is not an issue.  Readers should interpret reported effects 
by being aware that the population value may be outside the confidence interval for some 
of the effects. 
 3. Results 
All of the 34 participants who initially enrolled in the study completed the experimental 
trial.  However, one participant was excluded from data analysis due to non-compliance 
in regards to stepping rate during the experimental trial.   
 
A large difference is seen pre- to post- stair climb in both the immobilised and non-
immobilised groups across all four outcome measures.  These data are shown in Table 1. 
 
[Insert Table 1 here] 
 
A trivial to small difference in the immobilised and non-immobilised groups prior to the 
stair climbing task is observed in all four outcome measures. These data are shown in 
Table 2. 
 
[Insert Table 2 here] 
 
A trivial to small difference is observed across all four outcome measures post- stair 
climb in the immobilised and non-immobilised groups.  These data are shown in Table 3. 
 
[Insert Table 3 here] 
 
The physiological measures of oxygen uptake, heart rate, total energy cost and relative 
energy expenditure were on average higher in approximately half of the participants in 
the second trial when compared to the first.  A 5% average increase in heart rate, total 
energy cost and relative energy expenditure and an 8% average increase in oxygen uptake 
can be seen during the second stair climbing task when compared to the first stair 
climbing task.  This indicates that work load was higher in the second trial compared to 
the first.  Analysis was conducted to investigate if the order of immobilisation had any 
effect on the outcome measures.  This analysis shows that there is only a trivial to small 
effect of order of immobilisation on the four outcome measures.  These data are shown in 
Table 4.  
 Immobilisation of the dominant or non-dominant limb was not standardised between 
participants.  The data does not demonstrate considerable differences in the means or 
greater mean values across one condition (dominant or non-dominant) in any of the four 
outcome measures (oxygen uptake; 24 ± 5L.kg
-1
.min
-1
 and 25 ± 2L.kg
-1
.min
-1
, heart rate; 
155 ± 13beats.min
-1
 and 150 ± 18beats.min
-1
, total energy cost; 12900 ± 3200kcal.d
-1
 and 
12000 ± 1600 kcal.d
-1
, and relative energy expenditure; 171 ± 37 kcal.d
-1
.kg
-1
 and 179 ± 
14 kcal.d
-1
.kg
-1
 for dominant and non-dominant respectively).  Therefore statistical 
analysis was conducted to consider if immobilisation of the dominant verses the non-
dominant upper limb had any effect on the outcome measures.  This analysis 
demonstrates that there is only a trivial to small difference between the groups.  When the 
dominant arm is immobilised, the outcome measures are only slightly higher than the 
non-dominant arm data.  These data are shown in Table 4.  
 
[Insert Table 4 here] 
 
On observation of the individual results, it appears that for the majority of the participants 
the second stair climbing trial, irrespective of whether that the upper limb was 
immobilised or non-immobilised was metabolically more challenging across all observed 
outcome measures.  Plots of these data can be seen in Appendix 1.  Participants A to R 
conducted the immobilised trial second and the values over the four outcome measures 
are higher than the non-immobilised task.  This increase may be due to the fact that it is 
the second stair climbing task rather than the immobilisation itself.  Consistent with this, 
participants S to HH performed the non-immobilised trial second, showing higher values 
in the non-immobilised data sets across the four outcome measures.  For a few of the 
participants, the difference between the immobilised and non-immobilised data sets is 
either hard to distinguish, or mean increases or decreases are not seen over all four 
outcome measures. 
 
In contrast, four individuals show an increase across all four outcome measures during 
their first stair climbing trial.  For example, participant R found it more metabolically 
challenging over all the observed outcome measures to perform the first non-immobilised 
 trial than the subsequent immobilised trial.  Further, participants U, EE and GG exhibited 
an increase in each of the four outcome measures during their immobilised trial compared 
with the subsequent non-immobilised trial.  Plots of these data can be seen in Appendix 
2.  
 
Some individuals show a lag, or delay, in the time it took to reach end-point output 
readings.  Participant B and C (when immobilised) and participant HH (when non-
immobilised) demonstrate this lag in oxygen uptake, total energy cost and relative energy 
expenditure data (see Appendix 1).  To investigate this further, the time to reach half of 
the end-point oxygen uptake, total energy cost and relative energy expenditure for each 
participant was determined (see Table 5).  Heart rate data could not be utilised in this 
manner as for every participant the half end-point heart rate value was less than their 
initial resting heart rate measurement.  The time it took an individual (immobilised or 
non-immobilised) to reach half maximum output readings varied, ranging from one 
second to close to one minute.  As the apparatus sampled at a non-uniform rate and the 
data was relatively “noisy”, the readings are the closest approximation to the time at 
which half end-point readings were met.  The times to reach half the end-point readings 
within the immobilised and non-immobilised groups were within thirty seconds of each 
other, for all but one participant.  Participant B demonstrates a much greater time to reach 
half end-point value in the immobilised group (56 seconds longer) than in the non-
immobilised group (see Table 5). 
 
[Insert Table 5 here] 
 4. Discussion 
The objective of this study was to measure the effect of immobilisation of an upper limb 
on various physiological parameters during the everyday task of stair climbing. 
Following the stair climbing task, only a trivial to small difference in the immobilised 
and non-immobilised groups was demonstrated.  These results are in agreement with 
previous studies by Chapman & Ralston (1964), Park et al. (2000) and Hanada & 
Kerrigan (2001), all of which illustrated that unilateral immobilisation of an upper limb 
during a level walking task had no effect on total energy cost.   
 
Greenman (1996, p. 11) suggests that a musculoskeletal dysfunction places a greater 
demand on the individual as the dysfunction requires greater musculoskeletal activity and 
therefore imparts a greater energetic cost.  Therefore having an individual complete an 
exercise task that imposes a further metabolic cost, such as climbing a set of stairs, 
requires additional energy demand for which the musculoskeletal system has difficulty 
compensating for.  In our study however, a greater energetic cost could not be detected 
by imposing a musculoskeletal dysfunction through immobilisation of an upper limb 
during stair climbing at 80 steps.min
-1
.  The hypothesis of Greenman (1996, p. 11) is 
indeed true when the musculoskeletal dysfunction occurs in a joint of the lower 
extremity.  Not only has the increase in energetic cost been outlined by Greenman 
himself, who states that restriction of one major joint in the lower extremity can increase 
energy expenditure by up to 40% and restriction of two major joints in the same lower 
extremity by up to 300% (Greenman, 1996, p. 11), but Hanada & Kerrigan (2001), 
Abdulhadi, Kerrigan, & LaRaia (1996) and Mattsson & Brostrom (1990) all 
demonstrated increases in oxygen uptake when healthy participants had an imposed 
immobilisation of a knee or ankle joint.  The influence of hip musculoskeletal 
dysfunction on the energetic cost has been demonstrated in studies by Waters, Barnes, 
Husserl, Silver, & Liss (1988) and Mattsson (1989).  Waters et al. (1988) found a 32% 
increase in oxygen consumption in patients with unilateral hip arthrodesis compared to 
the asymptomatic control group and Mattsson (1989) reported that at a one year follow-
up of patients who had a total hip replacement, their oxygen uptake during a level 
walking task decreased from 0.27 L/kg/min
-1
 to 0.22 L.kg.min
-1
.  
 A large effect is observed pre- to post- stair climbing for oxygen uptake, heart rate, total 
energy cost and relative energy expenditure, showing that the physiological measures of 
oxygen uptake, heart rate, total energy cost and relative energy expenditure all 
considerably increase during the stair climbing task. The increase in values as a result of 
an exercise task is consistent with texts by previous authors (Bray, et al., 1986, p. 240; 
Guyton & Hall, 2000, p. 110; Marieb, 2004, p. 664; Wilmore, et al., 2008, p. 440).   
 
Physiological values prior to the stair climbing task are similar in both the immobilised 
and non-immobilised groups.  A trivial to small difference in the immobilised and non-
immobilised groups prior to the stair climbing task can be seen.  A trivial to small 
difference between the immobilised and non-immobilised groups prior to the stair 
climbing task indicates that the participants had returned to resting values before 
beginning the subsequent exercise task.  The fact that only such a negligible difference is 
seen in prior physiological values may indicate that the rest period of 15 to 45 minutes 
was adequate.   
 
On closer inspection of the individual participant‟s mean data, it was noted that 
approximately half of the participants showed higher outcome measure values in the 
immobilised stair climbing task than the non-immobilised task.  However, the majority 
demonstrated greater outcome measure values in the second stair climbing task in respect 
to the first task, based on observation of mean and individual data.  This posed the 
question of whether the order of immobilisation had an effect on the results, regardless of 
whether the upper limb was freely moving or immobilised.  Therefore, it is interesting 
that majority of the participants found the second stair climbing task harder than the first 
as analysis of mean data shows that order of immobilisation has a trivial to small effect. 
 
In contrast, four participants showed greater outcome measure values in the first stair 
climbing task than the second.  For three of these participants (U, EE, and GG) the arm 
was immobilised for the first exercise, while for participant R both arms moved freely 
(see Appendix 2 for data).  There are some noticeable similarities and differences 
between these four participants and all others in the study.  Two were male, two were 
 female, and all were aged between 19 and 26 years, which fits with the demographics of 
the remaining participants.  All four participants classified themselves as presently 
moderately active with a moderate level of fitness.  The only apparent point of difference 
was that one of the four was a regular smoker (approximately 15 cigarettes per day), of 
which there was only six others in the sample population.  Further to these identified 
differences, variation in the data of these four participants may be due to an uncontrolled 
variable such as anxiety or prior exercise. In light of these details, it remains unclear as to 
why these four participants found the first task stair climbing task more physiologically 
challenging. 
 
Observation of individual data plots shows a lag, or delay, in time to reach half end-point 
oxygen uptake in the immobilised data set for participants B and C and in the non-
immobilised data set of participant HH.  An early study by Craig (1972) suggests that an 
observed lag in oxygen uptake could be a delay in intramuscular vasodilatation in 
exercising skeletal muscle, therefore limiting the supply of oxygen to the muscle.  
Though, studies by Tschakovsky & Hughson (1999); Savard, Nielsen, Laszczynska, 
Larsen, & Saltin (1988) and Nielsen, Savard, Richter, Hargreaves, & Saltin (1990) to 
name a few, and the recent study by Nyberg, Mortensen, Saltin, Hellsten and Bangsbo 
(2010) suggest that muscle blood flow does not limit oxygen uptake during the initial 
stages of moderate intensity exercise.  Grassi et al. (1996) describes oxygen uptake 
during moderate intensity work as a three phase process.  The increase in oxygen uptake 
during the first two phases represents the circulatory system‟s ability to deliver oxygen, 
and the cells ability to utilise oxygen.  A lag or slowing in the oxygen kinetics in these 
two phases would limit the transportation and utilisation of oxygen in exercising skeletal 
muscle.  Further, it is conceivable that immobilisation of an upper limb could result in an 
impaired rib expansion, limiting the amount of inhaled oxygen rich air, and therefore 
reducing the oxygen available to exercising skeletal muscle.  Even though such oxygen 
kinetic and biomechanic arguments seem plausible, only two participants in the 
immobilised group show this lag, while only one demonstrates the same effect in the non-
immobilised group.  The reason as to why a difference is observed in these three 
participants remains unclear. 
 Limitations 
The exercise task set in this study may not have been intense enough to show a potential 
difference in energetic costs between dysfunctional and functional as would be predicted 
by Greenman (1996, p. 11). Other studies used level walking at a faster stepping rate than 
this study and reported a greater energetic cost when the upper limb is immobilised (Park, 
et al., 2000; Umberger, 2008). 
 
This study may be further limited as only the values at the conclusion of the stair climb 
were used in the analysis to determine any potential effect of dysfunction on the final 
energetic cost of stair climbing.  Consideration of the time taken to reach these values 
rather than the end-point values themselves may be more representative of the energetic 
burden of the exercise task.  The time to reach half end-point value can be calculated 
using equipment capable of accurate real time analysis and would be informative in 
future studies.  Additionally, it may be more informative to measure the time to reach 
end-point outcome measures in order to determine subtle differences in the immobilised 
and non-immobilised groups. 
 
As each participant did not repeat the stair climbing task in the reverse order and that 
immobilisation of the upper limb was not standardised across the participants these 
factors act as limitations to the study design. These limitations within the study design 
became apparent post data collection.  More accurate conclusions regarding the effect of 
upper limb immobilisation during a stair climbing task could be drawn if the study design 
had required the immobilised stair climbing task to be conducted both first (followed by 
climbing with the upper limbs freely moving) and second (preceded by climbing with the 
upper limbs freely moving).  This study randomly assigned which of the participant‟s 
upper limbs was immobilised.  This condition should be standardised in future studies. 
 
Practical constraints in this study meant that the rest period between trials (immobilised 
and non-immobilised) was not consistent between participants.  This time varied from 15 
to 45 minutes.  A 15 minute rest period may have been inadequate for some (or all) 
participants, and fatigue, either central and/or peripheral, may have had an impact on the 
 second trial (Stokes, Cooper, & Edwards, 1988).  Fatigue may explain the observation 
that the majority of the participants found the second stair climbing task more 
energetically demanding.  Although, a trivial to small difference was observed across the 
four outcome variables prior to the exercise task indicating that a considerable number of 
participants had outcome measure values pre-stair climb that were similar at the onset of 
the first and second exercise tasks.  A longer rest period would account for any increase 
in metabolic by-products as a result of the first task. 
 
Prior physical activity of any of the participants before the experimental trial would 
plausibly influence the data.  This variable was not adequately controlled in this study. 
 
  
 5. Conclusion 
In this sample population, within the limitations of this study, it can be concluded that 
immobilisation of the upper limb has only a trivial to small effect on oxygen uptake, heart 
rate, total energy cost, and relative energy expenditure during a stair climbing task.  This 
study therefore does not show any meaningful relationship between minor dysfunction 
(immobilisation of arm) and an increased metabolic demand hypothesised by Greenman 
(1996, p. 11).  
  
  
 
 
Figure 1.  A research participant wearing the Metamax 3B Cardiopulmonary system 
  
  
 
 
Figure 2.  The Metamax 3B cardiopulmonary system data receiver (foreground) and the 
Metasoft programme running on the computer (background) 
  
 
 
Figure 3.  A research participant wearing the Metamax 3B Cardiopulmonary system with 
their upper limb immobilised by a sling
 Table 1.  Changes in physiological parameters within the immobilised and non immobilised groups pre- to post- stair climb.  
 
 oxygen uptake 
(L.min
-1
.kg
-1
) 
heart rate  
(beats.min
-1
) 
total energy cost 
(kcal.d
-1
) 
relative energy expenditure 
(kcal.d-1.kg-1) 
Non-Immobilised 
1
     
PRE 
2
 0.5 ± 0.2 103 ± 19 3711 ± 1555 53 ± 23 
POST 
2 
1.9 ± 0.5 161 ± 16 13568 ± 3507 192 ± 39 
Mean Diff 
3
 72.3 36.2 72.6 72.2 
Upper CL 
4
 72.3 36.2 72.6 72.2 
Lower CL 
4
 72.3 36.2 72.6 72.2 
Magnitude 
5
 Large Large Large Large 
Likelihood of Difference 
6
     
Negative 0 0 0 0 
Trivial 100 100 100 100 
Positive 0 0 0 0 
Immobilised 
1
     
PRE 
2
 0.5 ± 0.2 106 ± 14 3362 ± 1419 48 ± 21 
POST 
2
 1.9 ± 0.4 165 ± 18 13861 ± 2717 198 ± 35 
Mean Diff 
3
 73.7 35.6 75.7 75.6 
Upper CL 
4
 73.7 35.6 75.7 75.6 
Lower CL 
4
 73.7 35.6 75.7 75.6 
Magnitude 
5
 Large Large Large Large 
Likelihood of Difference 
6
     
Negative 0 0 0 0 
Trivial 100 100 100 100 
Positive 0 0 0 0 
Note: 
1. Values are mean ± standard deviation. 
2. PRE= prior to stair climb; POST= at the conclusion of the stair climb. 
3. Difference between groups (expressed as a percent). 
4.  CL = 95% Confidence Limits (expressed as a percent). 
5. Magnitude of the effect based on Cohen (1988, p. 71) and Hopkins (2009) expresses the differences between the immobilised and non-immobilised groups 
6. Likelihood of difference, or clinical likelihood as indicated by Hopkins (2009) are expressed as a percent chance that the true differences between the immobilised and 
non immobilised groups are either that; the non immobilised task is more challenging in each of the four outcome variables (negative), that the immobilised task is more 
challenging, though the difference is negligible (trivial), or that the immobilised task demonstrates a substantial difference (positive). 
 Table 2.  Differences in physiological parameters between the immobilised and non-immobilised groups prior to the stair climb. 
 
Outcome 
measures 
NI 1 I
 1 Mean  Upper CL3 Lower CL3 Magnitude 4  Likelihood of Difference 5 
 Diff 2 Negative Trivial Positive 
oxygen uptake 
(L.min
-1
.kg
-1
) 
0.5 ± 0.2 0.5 ± 0.2 0 0.0 0.0 Trivial 0 100 0 
 
heart rate 
(beats.min
-1
) 
 
103 ± 19 
 
106 ± 14 
 
3.5 
 
7.6 
 
-0.6 
 
Small 
 
0 
 
54 
 
46 
 
total energy cost 
(kcal.d
-1
) 
 
3711 ± 1555 
 
3362 ± 
1419 
 
9.4 
 
20.7 
 
-1.9 
 
Small 
 
0 
 
14 
 
84 
 
relative energy 
expenditure 
(kcal.d-1.kg-1) 
 
 
53 ± 23 
 
 
48 ± 21 
 
 
9.8 
 
 
21.6 
 
 
-2.0 
 
 
Small 
 
 
1 
 
 
14 
 
 
85 
 
Note: 
1. Values are mean ± standard deviation.  NI = Non-Immobilised Group; I = Immobilised Group. 
2. Difference between groups (expressed as a percent). 
3. CL = 95% Confidence Limits (expressed as a percent). 
4. Magnitude of the effect based on Cohen (1988, p. 71) and Hopkins (2009) expresses the differences between the immobilised and non-immobilised 
groups 
5. Likelihood of difference, or clinical likelihood as indicated by Hopkins (2009) are expressed as a percent chance that the true differences between the 
immobilised and non immobilised groups are either that; the non immobilised task is more challenging in each of the four outcome variables (negative), 
that the immobilised task is more challenging, though the difference is negligible (trivial), or that the immobilised task demonstrates a substantial 
difference (positive). 
 
 
 
 Table 3.  Overall differences between immobilised and non immobilised groups in physiological parameters measured post- stair 
climb. 
 
Outcome 
measures 
NI 1 I 1 Mean 
Diff 2 
Upper CL3 Lower CL3 Magnitude 4 Likelihood of Difference 5 
 Negative Trivial Positive 
oxygen uptake 
(L.min
-1
.kg
-1
) 
1.37 ± 0.54 1.39 ± 0.43 0.63 6.9 -5.7 Trivial 9 75 16 
 
heart rate 
(beats.min
-1
) 
 
58 ± 16 
 
59 ± 16 
 
2.7 
 
2.7 
 
2.7 
 
Small 
 
0 
 
100 
 
0 
 
total energy cost 
(kcal.d
-1
) 
 
9858 ± 3560 
 
10499 ± 3062 
 
2.1 
 
8.8 
 
-4.6 
 
Trivial 
 
4 
 
64 
 
32 
 
relative energy 
expenditure 
(kcal.d-1.kg-1) 
 
 
139 ± 42 
 
 
149 ± 39 
 
 
2.6 
 
 
9.5 
 
 
-4.3 
 
 
Trivial 
 
 
4 
 
 
59 
 
 
37 
          
Note: 
1. Values are mean ± standard deviation.  NI = Non-Immobilised Group; I = Immobilised Group. 
2. Difference between groups (expressed as a percent). 
3. CL = 95% Confidence Limits (expressed as a percent). 
4. Magnitude of the effect based on Cohen (1988, p. 71) and Hopkins (2009) expresses the differences between the immobilised and non-immobilised 
groups 
5. Likelihood of difference, or clinical likelihood as indicated by Hopkins (2009) are expressed as a percent chance that the true differences between the 
immobilised and non immobilised groups are either that; the non immobilised task is more challenging in each of the four outcome variables (negative), 
that the immobilised task is more challenging, though the difference is negligible (trivial), or that the immobilised task demonstrates a substantial 
difference (positive). 
 Table 4. Mean differences in order of immobilisation and dominance between the 
immobilised and non-immobilised groups.  
 NI 1 I 1 Effect Size 2  Magnitude of Effect 2 
oxygen uptake (L.min
-1
.kg
-1
)     
NI/I 3 23 ± 5 23 ± 6 0 no effect 
NI/I DOM 4 23 ± 5 25 ± 5  0.40 small 
NI/I NON DOM 5 23 ± 5 22 ± 6 0.19 trivial 
I/NI 6 26 ± 6 26 ± 6 0 no effect 
I/NI DOM 7 25 ± 6 26 ± 6 0.17 trivial 
I/NI NON DOM 8 26 ± 6 26 ± 6 0 no effect 
heart rate (beats.min
-1
)     
NI/I 3 146 ± 14 152 ± 13 0.43 small 
NI/I DOM 4 146 ± 14 152 ± 13 0.43 small 
NI/I NON DOM 5 146 ± 14 153 ± 13 0.50 moderate 
I/NI 6 150 ± 15 154 ± 17 0.25 small 
I/NI DOM 7 145 ± 14 154 ± 17 0.56 moderate 
I/NI NON DOM 8 154 ± 17 154 ± 17 0.00 no effect 
total energy cost (kcal.d
-1
)     
NI/I 3 11550 ± 2675 11771 ±  2943 0.08 trivial 
NI/I DOM 4 11550 ± 2675 11485 ± 2695 0.02 trivial 
NI/I NON DOM 5 11550 ± 2675 12058 ± 3191 0.17 trivial 
I/NI 6 12843 ± 3140 12936 ± 3083 0.03 trivial 
I/NI DOM 7 12843 ± 3140 11946 ± 2888 0.29 small 
I/NI NON DOM 8 12843 ± 3140 13925 ± 3279 0.34 small 
relative energy expenditure  
(kcal.d
-1
.kg
-1
) 
    
NI/I 3 164 ± 39 167 ± 42 0.08 trivial 
NI/I DOM 4 164 ± 39 176 ± 42 0.3 small 
NI/I NON DOM 5 164 ± 39 157 ± 42 0.18 trivial 
I/NI 6  184 ± 45 184 ± 44 0 no effect 
I/NI DOM 7 184 ± 45 182 ± 44 0.05 trivial 
I/NI NON DOM 8 184 ± 45 187 ± 44 0.07 trivial 
Note: 
1. Values are mean ± standard deviation.  NI = Non-Immobilised Group; I = Immobilised Group. 
2. Effect size and magnitude of the effect are interpreted based on the criteria by Cohen (1988, p. 71) and Hopkins (2009),  
expressing the difference between the immobilised and non-immobilised groups. 
3. NI//I - non immobilisation followed by immobilisation (including either the dominant or the non dominant arm) 
4. NI/I DOM - non immobilisation followed by immobilisation of the dominant arm 
5. NI/I NON DOM - non immobilisation followed by immobilisation of the non dominant arm 
6. I/NI - immobilisation (either the dominant or non dominant arm) followed by non immobilisation 
7. I/NI DOM - immobilisation of the dominant arm followed by non immobilisation 
8. I/NI NON DOM - immobilisation of the non dominant arm followed by non immobilisation 
 Table 5.  Time to reach half end-point readings for immobilised and non-immobilised 
groups represented as one value1 for oxygen uptake, total energy cost and relative energy 
expenditure 
Participant NI 
2
 I 
2
 Difference
 3
 
A 00.01.13 00.00.54 -00.00.19 
B 00.00.31 00.01.28 00.00.56 
C 00.01.33 00.01.55 00.00.22 
D 00.00.06 00.00.24 00.00.18 
E 00.00.41 00.00.40 -00.00.01 
F 00.00.39 00.00.36 -00.00.03 
G 00.00.18 00.00.35 00.00.17 
H 00.00.15 00.00.20 00.00.05 
I 00.00.38 00.00.18 -00.00.20 
J 00.00.42 00.00.41 -00.00.01 
K 00.00.44 00.00.23 -00.00.21 
L 00.00.28 00.00.39 00.00.11 
M 00.00.27 00.00.35 00.00.08 
N 00.00.19 00.00.25 00.00.06 
O 00.00.38 00.00.27 -00.00.11 
P 00.00.15 00.00.09 -00.00.06 
Q 00.00.34 00.00.28 -00.00.06 
R 00.00.33 00.01.01 00.00.28 
S 00.00.32 00.00.38 00.00.06 
T 00.00.42 00.00.37 -00.00.05 
U 00.00.24 00.00.29 00.00.05 
V 00.00.37 00.00.35 -00.00.02 
W 00.00.10 00.00.24 00.00.14 
Y 00.00.28 00.00.38 00.00.10 
Z 00.00.27 00.00.40 00.00.13 
AA 00.00.40 00.00.32 -00.00.08 
BB 00.00.29 00.00.33 00.00.04 
CC 00.00.28 00.00.39 00.00.11 
DD 00.00.29 00.00.20 -00.00.09 
EE 00.01.00 00.01.01 00.00.01 
FF 00.00.36 00.00.21 -00.00.15 
GG 00.00.32 00.00.21 -00.00.11 
HH 00.00.25 00.00.26 00.00.01 
Note: 
1. Pelto et al. (1989) state that energy expenditure is dependent upon oxygen uptake.  Therefore, each 
participant the times to reach half end-point oxygen uptake, energy and relative energy 
expenditure values are shown as one value.   
2. Values are time, expressed as hours.minutes.seconds.  NI = non-immobilised condition; I = 
immobilised condition.  
3. Difference is expressed as the immobilised time value minus non-immobilised value. 
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Consent Form for Participants  
Effect of unilateral immobilization of the upper extremity on O2 consumption, heart rate and energy cost in stair 
climbing 
 
Participating in this study requires you to climb up a set of stairs to a metronome beat for five minutes under two 
experimental conditions, where your arms are swinging freely by your side as they would when you normally climb stairs, 
and with one of your arms immobilised using a sling.. During the trials, your heart rate and expired air volume will be 
measured, using a heart rate monitor placed around your chest, and by breathing into an apparatus throughout the duration 
of the trial.  Between trials you will have a 15 minute rest period to ensure you return to baseline measures. On each climb 
will be accompanied by the researcher to ensure that you follow the climbing beat, take one step at a time, not use the 
handrail or stop at any time during the experiment.  Additional information regarding your age, height and weight will be 
recorded before beginning the study. 
 
This research is being conducted by Kirsty Richardson from the Masters of Osteopathy at Unitec Institute of Technology, 
and will be supervised by Associate Professor Andy Stewart and Dr Graham Fordy.  Findings from this research will be 
used to complete the Master of Osteopathy degree and may be used within a published journal article. 
 
Name of Participant:…………………………………………………………………. 
 
I have seen the Information Sheet for participants taking part in the above Masters study. I have had the opportunity to 
read the contents of the information sheet and to discuss the study with the researching team and I am satisfied with the 
explanations I have been given.  I understand that taking part in this study is voluntary, that I can withdraw from the study 
up to two weeks post data collection, and that no data gained from the study can lead to my identification so that my 
anonymity is preserved. 
 
I understand that I can withdraw from the trial without any consequence if, for any reason, I want to. 
 
I understand that my participation in this study is confidential and that no data or information gained could breach this 
confidentiality. 
 
I have read and understood the health screening questionnaire and details given are accurate to my knowledge. 
 
I have no history of thrombosis, asthma which has required hospitalization in the last five years, gait disorders, upper 
motor neuron disease, cardiovascular disease, respiratory disease or rheumatological conditions which would exclude me 
from this study. 
 
I have had enough time to consider whether I want to take part. 
 
I know whom to contact if I have any questions or concerns about the study. 
 
The principal researcher for this study is Kirsty Richardson, who is contactable via email at 
kirstyleerichardson@gmail.com.  The supervisor, Associate Professor Andy Stewart can be contacted via email at 
astewart@unitec.ac.nz 
 
Signature of Participant……………………………………………………….                                                          ……….(date) 
 
Study explained by…………………………………………… 
 
Signature of Researcher ……………………………………………………….                                            ..…..…...(date) 
This study has been approved by the Unitec Research Ethics Committee from June 2008 to December 2009, approval number 862.   If you have any complaints or 
reservations about the ethical conduct of this research, you may contact the Committee through the UREC Secretariat (Ph: 09 815-4321 ext 7254).  Any issues you 
raise will be treated in confidence and investigated fully, and you will be informed of the outcome
Appendix Three 
  
Information Sheet for Participants  
Effect of unilateral immobilization of the upper extremity on O2 consumption, heart rate and energy cost in stair 
climbing 
Introduction 
I am a Masters of Osteopathy student, who is currently undertaking research as part of my course requirements.  I am 
doing research on the effect of unilateral upper extremity immobilization on oxygen consumption, heart rate and energy 
cost of stair climbing.  My aims are to see if immobilisation has any effect on each of these parameters, and the possible 
implications of immobilisation when exercising.  This will be achieved by individuals walking up stairs for five minutes 
with their arms swinging freely, and then repeated with one of their arms movement being restricted by a sling.   
 
What is being asked of you? 
This study requires you to walk up a flight of stairs twice, five minutes each time, once with your arms swinging freely 
then with one arm being immobilized, with a rest period of 15 minutes between trials.  During the trial, you will have your 
heart rate measured by a device placed around your chest and your expired air volume by breathing into a mouthpiece.  
You will be accompanied on your climb to ensure that you follow the guidelines of the trial, following the climbing beat, 
taking one step at a time, not using the handrail or stop at any time during the experiment.  You will be randomly 
allocated to which trial you complete first dependent on your registration to the study.  Additional information regarding 
your age, height and weight will be recorded before beginning the study. 
 
What does this mean for you as a participant? 
 You have to be walking more than one flight of stairs at least once a week as part of your everyday living, be 
pain-free during walking, and have no existing shoulder complaint or injury, or had a complaint or injury over the 
last year.   
 You cannot participate if you have any gait disorders, upper motor neuron disease, cardiovascular or respiratory 
disease or rheumatological conditions 
 You cannot participate if you have a history of thrombosis, or asthma which has required hospitalization in the 
last five years 
 Participation is your choice, and you have the option to withdraw from the study up to two weeks post data 
collection, with no consequences. 
 Data gained doesn‟t require you to supply any personal information that could lead to your identification, so your 
confidentiality is preserved. 
 You are free to contact the researcher regarding any concerns or queries. 
 Data gained from this research will be used for submission of a Masters of Osteopathy thesis and may be used 
within a published journal article following the completion of the Masters degree.  
 
Confidentiality 
The researcher aims to ensure that the information you have given is kept confidential.  Data retrieved from the trial will 
be numbered, keeping the results confidential and will be entered within a computer programme that only the researcher 
and her supervisors can access.  Raw copies of the data will be stored for five years following the study and will then be 
destroyed. 
Consent 
This information will be repeated to you before the commencement of the study with an opportunity for you to clear any 
doubts or concerns.  Both verbal and written consent will be gained from you and it is taken as an indication that you 
consent to participate in this study. 
 
Thank you very much for your participation.  If you have any questions or enquires at any time during the course of the 
study or following the completion of the study, please don‟t hesitate to contact me or my supervisor via email at 
kirstyleerichardson@gmail.com or astewart@unitec.ac.nz. 
 
This study has been approved by the Unitec Research Ethics Committee from June 2008 to December 2009, approval number 862.  I f you have any complaints or 
reservations about the ethical conduct of this research, you may contact the Committee through the UREC Secretariat (Ph: 09 815-4321 ext 7254).  Any issues you 
raise will be treated in confidence and investigated fully, and you will be informed of the outcome. 
  
Health Screening Questionnaire  
Effect of unilateral immobilization of the upper extremity on O2 consumption, heart rate and energy cost in stair 
climbing 
 
Name: _________________________________________________ Date of Birth:________________________  
 
Activity Status: 
How would you describe your present level of activity? (Please circle) 
 
 Sedentary  Moderate  Active   Highly Active 
 
How would you describe your level of fitness? (Please circle) 
 
 Unfit   Moderate  Fit   Trained 
 
Medical Status: 
1. Do you have a history of cardiovascular or respiratory disorder?    Y / N 
2. Do you have a history of high blood pressure?       Y / N  
3. Do you suffer from dizziness?        Y / N 
4. Do you suffer from thrombosis?        Y / N 
5. Do you have a previous/current injury that may impede your ability to exercise?   Y / N  
6. Have you consulted a doctor in the last 6 months for exercise related reasons?   Y / N  
7. Are you currently taking any form of medication?      Y / N 
8. Have you ever suffered from asthma which required hospitalization in the last five years? Y / N 
9. Do you suffer from any gait disorders, which impedes your ability to walk?   Y / N   
10. Do you suffer from any rheumatological condition (eg osteoarthritis, rheumatoid arthritis)? Y / N 
11. Do you suffer from an upper motor neuron disease (eg multiple sclerosis)?   Y / N 
If you have answered YES to any of the above please give details below: 
 
---------------------------------------------------------------------------------------------------------------- 
 
Smoking habits: (Please circle) 
Never 
Used to Smoke    How many/day? ---------- 
Occasionally Smoke   How many/day? ---------- 
Regularly Smoke   How many/day? ---------- 
 
Declaration 
 
I declare that all information given above has been read, understood and is correct to the best of my knowledge. 
 
Signature:_______________________________________________ Date:_____________________________ 
 
 Appendix Four 
 
Submission Criteria for Gait and Posture:  Guide for Authors 
 
Official Journal of: Gait and Clinical Movement Analysis Society (GCMAS), European Society of Movement 
Analysis in Adults and Children (ESMAC), Società Italiana di Analisi del Movimento in Clinica (SIAMOC), 
and the International Society for Posture and Gait Research (ISPGR). 
 
Authors should submit online  http://ees.elsevier.com/gaipos. This is the Elsevier web-based 
submission and review system. You will find full instructions located on this site in the Tutorial for Authors. 
Please follow the guidelines to prepare and upload your article. Once the uploading is done, the system 
automatically creates an electronic pdf which is used for reviewing. All correspondence, including 
notification of the Editor's decision and requests for revisions, will be managed via this system. 
 
A manuscript submitted to this journal can only be published if it (or a similar version) has not been 
published and will not be simultaneously submitted or published elsewhere. A violation of this condition is 
considered fraud, and will be addressed by appropriate sanctions. Two manuscripts are considered similar 
if they concern the same hypothesis, question or goal, using the same methods and/or essentially similar 
data. 
 
Preparation of the Manuscript 
1. Article types accepted are: Original Article (Full paper or Short Communication), Review Article, 
Technical Note, Book Review. Word limits including the abstract are as follows: Full paper 3,000 words 
plus no more than 5 figures/tables in total; Short Communication or Technical Note 1,200 words plus no 
more than 3 figures/tables in total. If the Editor feels that a paper submitted as a Full Paper would be 
more appropriate for the Short Communications section, then a shortened version will be requested. 
References should be limited to 30 for Full Papers, 15 for Short Papers and 10 for Technical Notes. An 
abstract not exceeding one paragraph of 250 words should appear at the beginning of each Article. The 
recommended word limit for Review Papers is 6,000 words. Authors must state the number of words when 
submitting. 
 
2. All publications will be in English. Authors whose 'first' language is not English should arrange for their 
manuscripts to be written in idiomatic English before submission. A concise style avoiding jargon is 
preferred. 
 
3. Authors should supply up to five keywords that may be modified by the Editors. 
 
4. Acknowledgements should be included in the title page. Include external sources of support. 
 
5. The text should be ready for setting in type and should be carefully checked for errors. Scripts should 
be typed double-spaced on one side of the paper only. Please do not underline anything, leave wide 
margins and number every sheet. 
 
6. All illustrations should accompany the typescript, but not be inserted in the text. Refer to photographs, 
charts, and diagrams as 'figures' and number consecutively in order of appearance in the text. Substantive 
captions for each figure explaining the major point or points should be typed on a separate sheet. 
 
 
7. Tables should be presented on separate sheets of paper and labelled consecutively but the captions 
should accompany the table.  
 
8. Authors should also note that files containing text, figures, tables or multimedia data can be placed in a 
supplementary data file which will be accessible via ScienceDirect (see later section for further details). 
  
9. When submitting you paper please ensure that you separate any identifying author or institution of 
origin names and details and place them in the title page (with authors and addresses). Submissions 
including identifying details in the manuscript text will be returned to the author. 
  
Summary of Overall Arrangement of Manuscripts  
You should arrange your contribution in the following order: 
 
1. A cover page with complete details of the title, the source, and the authors full contact details. 
Acknowledgements should be placed on this page. 
2.  An abstract outlining the purpose, scope and conclusions of the paper. 
3. The text suitably divided under headings. (frequently Introduction, Material or Patients, Methods, 
Results, Discussion will prove satisfactory) 
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